58M presents with 45-minute chest pain, anterior ST elevation in V1βV4. We are a non-PCI capable center. Nearest cath lab is 2 hours away. ACC/AHA guidelines recommend primary PCI if door-to-balloon time is under 120 minutes from first medical contact. In our scenario, fibrinolysis seems indicated. What are the key contraindications to check before administering alteplase, and should we transfer post-lysis regardless of clinical reperfusion signs?
Per ACC/AHA 2013 STEMI guidelines, primary PCI is the preferred reperfusion strategy if door-to-balloon (D2B) time is β€90 min (or β€120 min from first medical contact). Fibrinolysis is preferred when: (1) PCI is unavailable at the presenting facility, AND (2) expected D2B time exceeds 120 minutes from first medical contact. Before administering alteplase, check the following absolute contraindications: - Any prior intracranial hemorrhage - Known structural cerebrovascular lesion (AVM) - Ischemic stroke within 3 months - Active internal bleeding (not menses) - Suspected aortic dissection - Significant closed-head/facial trauma within 3 months - Intracranial/intraspinal surgery within 2 months - Severe uncontrolled hypertension unresponsive to therapy Key relative contraindications: BP >180/110, INR >2, active peptic ulcer, pregnancy, prior non-hemorrhagic stroke >3 months ago. Regarding post-lysis transfer: YES β all patients who receive fibrinolysis should be transferred to a PCI-capable center regardless of apparent clinical reperfusion. Current guidelines recommend coronary angiography within 3β24 hours of successful fibrinolysis (pharmacoinvasive strategy). If fibrinolysis fails (less than 50% ST resolution at 60β90 min, persistent pain, hemodynamic instability), immediate rescue PCI is indicated.
Be specific. Cite references where possible. Your credentials will be shown with your answer.